Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
17 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
3 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
4 Mar 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
19 Dec 23
8-K
Changes in Registrant's Certifying Accountant
24 Oct 23
8-K
Departure of Directors or Certain Officers
20 Oct 23
8-K
Envoy Medical Announces Settlement Contract
10 Oct 23
8-K/A
Financial Statements and Exhibits
10 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination
29 Sep 23
8-K
Anzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation
27 Sep 23
8-K
ENVOY MEDICAL | 1 Investor Presentation Hear for Life September 2023
15 Sep 23
Registration and prospectus
S-1/A
IPO registration (amended)
25 Apr 24
S-8
Registration of securities for employees
12 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
S-1/A
IPO registration (amended)
14 Feb 24
S-1
IPO registration
18 Jan 24
25-NSE
Exchange delisting
29 Sep 23
425
Business combination disclosure
15 Sep 23
424B3
Prospectus supplement
14 Sep 23
Proxies
DEFA14A
Additional proxy soliciting materials
15 Sep 23
DEF 14A
Definitive proxy
15 Sep 23
PRE 14A
Preliminary proxy
5 Sep 23
DEFA14A
Additional proxy soliciting materials
24 Feb 23
DEFA14A
Additional proxy soliciting materials
22 Feb 23
DEFA14A
Additional proxy soliciting materials
21 Feb 23
DEFA14A
Additional proxy soliciting materials
21 Feb 23
DEFA14A
Additional proxy soliciting materials
9 Feb 23
DEFA14A
Additional proxy soliciting materials
6 Feb 23
DEFA14A
Additional proxy soliciting materials
2 Feb 23
Other
EFFECT
Notice of effectiveness
15 Sep 23
CORRESP
Correspondence with SEC
14 Sep 23
CORRESP
Correspondence with SEC
13 Sep 23
CORRESP
Correspondence with SEC
12 Sep 23
UPLOAD
Letter from SEC
12 Sep 23
CORRESP
Correspondence with SEC
1 Sep 23
UPLOAD
Letter from SEC
1 Sep 23
CORRESP
Correspondence with SEC
23 Aug 23
UPLOAD
Letter from SEC
18 Aug 23
CORRESP
Correspondence with SEC
4 Aug 23